The secreted IL‐6 activates the JAK/STAT3 pathway in BC cells to increase EIF4A3 and CCL2 levels, which further promotes the biogenesis of cSERPINE in a positive feedback mechanism, resulting in increased invasion, metastasis, and poor patient survival [79]. Here, IL6 is linked to breast cancer.